Acumen Pharmaceuticals, Inc. (Nasdaq:ABOS)
Health Care/Life Sciences • Pharmaceuticals
CIK 1576885
Company
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Address
427 Park Street
Charlottesville, Virginia 22902
427 Park Street
Charlottesville, Virginia 22902
Employees
40
40
Stock Info
Close
$4.2800
$4.2800
Day Range
4.2600 - 4.4900
4.2600 - 4.4900
52 Week Range
1.8101 - 11.3099
1.8101 - 11.3099
Average volume
439.98K
439.98K
Short Interest
773.35K (02/29/24)
773.35K (02/29/24)
% of Float Shorted
1.86%
1.86%
Market Cap
$253.07M
$253.07M
Revenue
N/A
N/A
Net Income
-$42.86M
-$42.86M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Independent Director Jeffrey L Ives PhD |
Independent Director Laura Stoppel PhD |
Independent Director Derrell D Porter MD, MBA |
Independent Director Nathan B Fountain MD |
Independent Director Kimberlee Cobleigh Drapkin CPA |
Independent Director Sean Stalfort |
SEC filings
Date | Form | Event |
---|---|---|
12 Nov, 2024 | 8-K | |
12 Nov, 2024 | 10-Q | |
6 Nov, 2024 | 3 | |
6 Nov, 2024 | 4 | |
13 Aug, 2024 | 10-Q | |
13 Aug, 2024 | 8-K | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
5 Jun, 2024 | 8-K | |
14 May, 2024 | 8-K | |
14 May, 2024 | 10-Q | |
24 Apr, 2024 | EFFECT | |
22 Apr, 2024 | DEFA14A | |
22 Apr, 2024 | CORRESP | |
22 Apr, 2024 | ARS | |
22 Apr, 2024 | DEF 14A | |
2 Apr, 2024 | UPLOAD | |
27 Mar, 2024 | S-3 | |
27 Mar, 2024 | S-8 | |
26 Mar, 2024 | 10-K | |
26 Mar, 2024 | 8-K | |
19 Mar, 2024 | 8-K | |
14 Feb, 2024 | SC 13G/A | |
6 Feb, 2024 | SC 13G | |
1 Feb, 2024 | 3 | |
1 Feb, 2024 | 8-K | CEO Change |
1 Feb, 2024 | 4 | |
24 Jan, 2024 | SC 13G/A | |
18 Jan, 2024 | 144 | |
18 Jan, 2024 | 144 | |
18 Jan, 2024 | 144 | |
12 Jan, 2024 | 8-K | |
8 Jan, 2024 | 8-K | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
4 Dec, 2023 | 8-K | |
13 Nov, 2023 | 10-Q | |
13 Nov, 2023 | 8-K | |
13 Nov, 2023 | 8-K | |
9 Nov, 2023 | 8-K | |
18 Aug, 2023 | 4 | |
17 Aug, 2023 | 144 | |
8 Aug, 2023 | 10-Q | |
8 Aug, 2023 | 8-K | |
25 Jul, 2023 | 4 | |
25 Jul, 2023 | SC 13D/A | |
20 Jul, 2023 | 8-K | |
20 Jul, 2023 | 424B5 | |
17 Jul, 2023 | 424B5 | |
17 Jul, 2023 | 8-K | |
17 Jul, 2023 | 8-K | |
13 Jun, 2023 | 4 | |
8 Jun, 2023 | 8-K | |
7 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
7 Jun, 2023 | 4 | |
9 May, 2023 | 8-K | |
9 May, 2023 | 10-Q | |
28 Apr, 2023 | DEFA14A | |
27 Apr, 2023 | ARS | |
27 Apr, 2023 | 424B5 | |
27 Apr, 2023 | 8-K | |
27 Apr, 2023 | DEF 14A | |
14 Apr, 2023 | PRE 14A | |
28 Mar, 2023 | S-8 | |
27 Mar, 2023 | 8-K | |
27 Mar, 2023 | 10-K | |
15 Mar, 2023 | 8-K | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
1 Feb, 2023 | 8-K | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
18 Jan, 2023 | 4 | |
4 Jan, 2023 | 4 | |
4 Jan, 2023 | 3 | |
4 Jan, 2023 | 8-K | |
3 Jan, 2023 | 4 | |
14 Nov, 2022 | 8-K | |
14 Nov, 2022 | 10-Q | |
24 Oct, 2022 | 8-K | |
7 Oct, 2022 | SC 13G/A | |
12 Sep, 2022 | 8-K | |
7 Sep, 2022 | 3 | |
7 Sep, 2022 | 4 | |
15 Aug, 2022 | 8-K | |
15 Aug, 2022 | 10-Q | |
1 Aug, 2022 | 8-K | |
8 Jul, 2022 | EFFECT | |
6 Jul, 2022 | UPLOAD | |
6 Jul, 2022 | CORRESP | |
1 Jul, 2022 | S-3 | |
21 Jun, 2022 | 4 | |
21 Jun, 2022 | 8-K | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
16 May, 2022 | 8-K | |
16 May, 2022 | 10-Q | |
27 Apr, 2022 | DEFA14A | |
27 Apr, 2022 | DEF 14A | |
4 Apr, 2022 | 3 | |
4 Apr, 2022 | 4 | |
29 Mar, 2022 | S-8 | |
28 Mar, 2022 | 10-K | |
28 Mar, 2022 | 8-K | |
16 Feb, 2022 | SC 13G | |
15 Feb, 2022 | SC 13G | |
14 Feb, 2022 | SC 13G | |
4 Feb, 2022 | SC 13G | |
27 Jan, 2022 | SC 13G | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
3 Jan, 2022 | 8-K | |
2 Dec, 2021 | 4 | |
15 Nov, 2021 | 10-Q | |
15 Nov, 2021 | 8-K | |
10 Nov, 2021 | 8-K | |
7 Oct, 2021 | 8-K | |
13 Sep, 2021 | SC 13D/A | |
31 Aug, 2021 | 8-K | |
16 Aug, 2021 | 10-Q | |
16 Aug, 2021 | 8-K | |
16 Jul, 2021 | SC 13D | |
13 Jul, 2021 | SC 13G | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 3/A | |
8 Jul, 2021 | 4 | |
8 Jul, 2021 | 4 | |
7 Jul, 2021 | 8-K | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | S-8 | |
2 Jul, 2021 | 424B4 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | SEC STAFF | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | EFFECT | |
30 Jun, 2021 | S-1MEF | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
30 Jun, 2021 | 3 | |
29 Jun, 2021 | CERT | |
28 Jun, 2021 | CORRESP | |
28 Jun, 2021 | 8-A12B | |
28 Jun, 2021 | CORRESP | |
24 Jun, 2021 | S-1/A | |
24 Jun, 2021 | CORRESP | |
16 Jun, 2021 | CORRESP | |
14 Jun, 2021 | UPLOAD | |
9 Jun, 2021 | CORRESP | |
9 Jun, 2021 | S-1 | |
7 Jun, 2021 | SEC STAFF | |
3 Jun, 2021 | DRS/A | |
25 May, 2021 | UPLOAD | |
14 May, 2021 | DRS/A | |
14 May, 2021 | DRSLTR | |
10 May, 2021 | UPLOAD | |
12 Apr, 2021 | DRS |
Last update:2024-03-12 12:03:44.361118
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.